Geode Capital Management, LLC Acrivon Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 302,103 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
302,103
Previous 308,393 2.04%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
N/A
-6,290 Reduced 2.04%
302,103 $0
Q2 2024

Aug 09, 2024
BUY
N/A
65,547 Added 26.99%
308,393 $0
Q1 2024

May 13, 2024
BUY
N/A
53,646 Added 28.35%
242,846 $0
Q4 2023

Feb 13, 2024
SELL
N/A
-359 Reduced 0.19%
189,200 $0
Q3 2023

Nov 13, 2023
BUY
N/A
11,106 Added 6.22%
189,559 $0
Q2 2023

Aug 11, 2023
BUY
N/A
3,049 Added 1.74%
178,453 $0
Q1 2023

May 15, 2023
BUY
N/A
175,404 New
175,404 $0

Others Institutions Holding ACRV

# of Institutions
53
Shares Held
23.2M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email